Publication
Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial
Sharana Mahomed, Sharana Mahomed, Nigel Garrett, Nigel Garrett, Quarraisha A Karim, Quarraisha A Karim, Nonhlanhla Y Zuma, Nonhlanhla Y Zuma, Edmund Capparelli, Edmund Capparelli, Cheryl Baxter, Cheryl Baxter, Tanuja Gengiah, Tanuja Gengiah, Derseree Archary, Derseree Archary, Natasha Samsunder, Natasha Samsunder, Nicole Doria-Rose, Nicole Doria-Rose, Penny Moore, Penny Moore, Carolyn Williamson, Carolyn Williamson, Dan H Barouch, Dan H Barouch, Patricia E Fast, Patricia E Fast, Bruno Pozzetto, Bruno Pozzetto, Catherine Hankins, Catherine Hankins, Kevin Carlton, Kevin Carlton, Julie Ledgerwood, Julie Ledgerwood, Lynn Morris, Lynn Morris, John Mascola, John Mascola, Salim Abdool Karim, Salim Abdool Karim
BMJ Open, November 2020, BMJ
DOI: 10.1136/bmjopen-2020-042247